Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Similar documents
Impact of Endoscopic Versus Open Saphenous Vein Harvest Techniques on Outcomes After Coronary Artery Bypass Grafting

Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison

Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG, an Angiographically Measured Graft Patency Comparison

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Listen to your heart: Good Cardiovascular Health for Life

Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery Bypass Grafting

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

HA Territory-wide PCI Audit

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

The Bioresorbable Vascular Stent Dr Albert Ko

Perioperative Cardiac Evaluation

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Cilostazol versus Clopidogrel after Coronary Stenting

Declaratory Ruling Replaces Declaratory Ruling 97-2

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Main Effect of Screening for Coronary Artery Disease Using CT

The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest. Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases

Duration of Dual Antiplatelet Therapy After Coronary Stenting

The return of myocardial ischemia after coronary artery

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Antonio Colombo MD on behalf of the SECURITY Investigators

Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Clinical Practice Assessment Robotic surgery

Prognostic impact of uric acid in patients with stable coronary artery disease

PHYSICIAN ASSISTANTS IN CARDIAC SURGERY

Surgeons Role in Atrial Fibrillation

06 Validation of risk prediction model

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

CARDIAC RISKS OF NON CARDIAC SURGERY

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA

Non-surgical treatment of severe varicose veins

January 2016, Volume: 8, Issue: 1, Pages: , DOI:

Description of problem Description of proposed amendment Justification for amendment ERG response

Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

LEADERS: 5-Year Follow-up

Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial

Evidence tabel Lokaal palliatieve behandelingen

PCI vs. CABG for Left Main Disease

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Minimally Invasive Mitral Valve Surgery

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN

Alexander Chernyavskiy 1, Alexander Volkov 1, Oleg Lavrenyuk 1, Igor Terekhov 1 and Yulia Kareva 1,2*

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

Zhongmin Li, PhD University of California, Davis School of Medicine

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany

Surgical Site Infection Prevention

Laparoscopic Repair of Incisional Hernia. Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

Medical Translusion and Endoscopic Vein Harvesting - A Review

A Master class in Conduit surgery for CABG

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

Managing the lower limb in coronary artery bypass grafting

Appendix G - Identification and Selection of Studies

Series 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required

Cardiac Rehab. Home. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

The Cardiac Society of Australia and New Zealand

Long-Term Effect of Dual Antiplatelet Treatment after Off-Pump Coronary Artery Bypass Grafting

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

REFLECTIONS: FORTY YEARS OF VASCULAR CARE

Imaging of Thoracic Endovascular Stent-Grafts

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

Public reporting improves healthcare. Jack Chen MBBS PhD MBA

Roux-en-Y Gastric Bypass

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

The Effects of Short-term Cardiac Rehabilitation on Post-CABG Patients Fitness

Your Guide to Express Critical Illness Insurance Definitions

Value-Based Purchasing

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

MEDICAL POLICY No R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care Methodology Contents

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI)

ABOUT XARELTO CLINICAL STUDIES

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS

Utilization Review Cardiac Rehabilitation Services: Underutilized

INFORMED CONSENT FOR SLEEVE GASTRECTOMY

Scelte Antitrombotiche nelle SCA delle UTIC Italiane: Nuovi Dati dal Registro EYESHOT

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

Transcription:

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben als erstes die MIVH Technik bei 30 Patienten durchgeführt unter Verwendung des MiniHarvest System (US Surgical Corporation, Norwalk, Conn) 1996 Lumsden und Kollegen haben als erstes die EVH bei 30 Patienten durchgeführt und beschrieben (Georgia, USA) 1.Tevaearai HT et al. Minimally invasive harvest of the saphenous vein for coronary artery bypass grafting. Ann Thorac Surg. 1997;63(6):119-121 2.Lumsden AB et al. Subcutaneous, veideo-assisted saphenous vein harvest: report of the first 30 cases. Cardiovasc Surg. 1996; 4(6): 771-6

EVH Einsatz und Verbreitung in den USA 1 90% 92% 93% 0,8 0,6 65% 70% 76% 55% 82% 62% 71% 73% 76% 46% 0,4 0,2 0 2% 7% 15% 20% 28% 36% 1997 1998 1999 2000 2001* 2002 2003 2004 2005 2006 2007 2008E USER ADOPTION (% of hospitals using EVH) PENETRATION (% of CABG cases using EVH)

EVH in den USA und Europa

EVH Vorteile vs. OVH Geringeres chirurgisches Trauma Inzisionslänge, Blutverlust, Schmerzen, postoperative Immunfunktion schnellere Rekonvaleszenz geringere postop. Wundheilungsstörungen befriedigenderes kosmetisches Ergebnis (Kostenreduktion) Patientenzufriedenheit

EVH vs. OVH Kosmetisches Resultat offen endoskopisch

EVH vs. OVH Wundheilung 2-25%

EVH Patientenauswahl Keine Adipositas permagna Keine extrem oberflächliche Vena saphena Keine Seitenastvarikosis Keine Gerinnungsauffälligkeiten Keine Notfälle Nur selektiertes Patientengut

EVH Nachteile vs. OVH Bypass-Versagen Fehlende Langzeitergebnisse Längere Operationszeiten Kostenerhöhung

EVH vs. OVH aktuelle Datenlage Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Meta-Analysis of Randomized Trials and Controlled Trials Innovations 2005 Objective: EVH improves clinical and resource outcomes compared with OVH in adults undergoing CABG Methods: Comprehensive literature search (Medline, Embase ) to identify all randomized and nonrandomized trials of EVH vs. OVH up to April 2005 Primary outcome: wound complications Secondary outrcomes: any other clinical morbidity and resource utilization Results: 36 trials of 9.632 patients 13 randomized (1.319 patients) 23 nonrandomized (8.313 patients) 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery 2005. Innovations. 2005; 1:51-60.

EVH vs. OVH aktuelle Datenlage Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Meta-Analysis of Randomized Trials and Controlled Trials Innovations 2005 Results: Risk of wound complications Risk of wound infections Need for surgical wound intervention significantly reduced by EVH vs. OVH Incidence of pain, neurolgia, patient satisfaction improved with EVH vs. OVH Postop. MI, stroke, reintervention, AP quality of graft not significantly different betw. EVH vs. OVH Operative time significantly increased by EVH 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery 2005. Innovations. 2005; 1:51-60.

EVH vs. OVH aktuelle Datenlage 2005 The International Society for Minimally Invasive Cardiac Surgery (ISMICS) Consensus Conference suggest: Innovations 2005 EVH is recommended to reduce wound related complications, improve patient satisfaction, and decrease postop. pain, hospital LOS, and outpatient wound management resources when compared to OVH (Class I; Level A) Based on quality of conduit harvested, either EVH or OVH technique may be used (Class IIa; Level B) Based on major adverse cardiac events and angiographic patency at 6 months, either EVH or OVH technique may be used (Class IIa; Level A) Conclusion: EVH should be considered the standard of care for patients who require saphenous vein grafts for coronary bypass surgery 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery 2005. Innovations. 2005; 1:51-60.

EVH vs. OVH aktuelle Datenlage Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery N Engl J Med 2009 Objective: Effect of EVH on vein-graft failure as assessed by angiography 12 to 18 months and on long-term clinical outcomes Methods: 3.000 patients undergoing CABG (1.753 EVH; 1247 OVH); randomized, 107 centers Primary outcome: vein-graft failure (defined as >75% stenosis of graft on angio.) Clinical outcomes: death, MI, repeat revascularization (3 year follow-up period) Results: EVH significantly higher rates of vein-graft failure at 12 to 18 months than OVH (46.7% vs. 38.0%, P<0.001) EVH associated with higher rates of death, MI, or repeat revascularization after 3 y (20.2% vs. 17.4%, P=0.04) A 4. Lopes RD, Hafley GE, Allen KB et al. Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery: N Engl J Med. 2009; 361(3): 235-44

EVH vs. OVH aktuelle Datenlage Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting Objective: Assess the effect of EVH on short-term and midterm outcomes after CABG Ann Thorac Surg 2010 Methods: 1998-2007 at a single center (Canada); data prospectively collected 5.825 patients undergoing first time isolated CABG and combined valve/cabg 2.004 (34.4%) patients EVH; 3.821 (65.6%) patients OVH (continuous/bridging) Short-term outcomes: Midterm outcomes: leg infections, in-hospital mortality, all-cause mortality, readmission to hospital for cardiac catheterization, repeat revascularization, unstable angina, MI, heart failure median follow-up 2.6 years 5. Ouzounian M et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting: Ann Thorac Surg. 2010; 89(2): 403-8 A

EVH vs. OVH aktuelle Datenlage Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting Ann Thorac Surg 2010 Results: EVH associated with reduced rates of leg infection (1.1% vs. 2.2%, p=0.003) EVH similar rates of in-hospital mortality compared with OVH (3.2% vs. 4.0%, p=0.16) EVH no association with midterm adverse outcomes (hazard ratio 0.93, p=0.22) EVH and OVH similar freedom from death or readmission to hospital for cardiac cause EVH associated with reduced rate of readmission to hospital for unstable angina (hazard ratio 0.74), but not for MI Conclusion: EVH is not an independent predictor of in-hospital or midterm adverse outcomes 5. Ouzounian M et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting: Ann Thorac Surg. 2010; 89(2): 403-8

A EVH vs. OVH aktuelle Datenlage Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Objective: Explore use of EVH and influence on perioperative and long-term outcomes Circulation 2011 Methods: 2001-2004 at a 8 centers (north. New Engl.); data prospectively collected 8.542 patients undergoing first time isolated CABG (excluded: <30y, emergency surgery, life-threatening malignancy, TAR, radial artery) 4.480 (52.5%) patients EVH; 4.062 (47.5%) patients OVH (continuous incision) Short-term outcomes: Long-term outcomes: in-hospital morbidity and mortality mortality and repeat revascularization (CABG or PCI) follow-up 4 years 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2): 147-53

EVH vs. OVH aktuelle Datenlage Results: Long-term outcome: Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 mortality Figure 1. Adjusted risk of mortality by vein harvesting approach (2001 to 2004). The HR is for EVH relative to OVH related to mortality. Adjusted for age, sex, EF, vascular disease, DM, BMI 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2): 147-53

EVH vs. OVH aktuelle Datenlage Results: Long-term outcome: Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 repeat revascularization Figure 2. Adjusted risk of repeat revasculariztaion by vein harvesting approach (2001 to 2004). The HR is for EVH relative to OVH related to risk of repeat revascularization. Adjusted for age, sex, EF, vascular disease, DM, BMI, 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2): 147-53

EVH vs. OVH aktuelle Datenlage Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 Results: In-Hospital outcomes: Use of OVH associated with an increased postop. leg wound infection (P<0.001) EVH associated with an increase in return to operating room for bleeding (P=0.03) Long-Term outcomes: EVH significantly associated with a reduced risk of mortality EVH associated with an insignificant increased risk of repeat revascularization Conclusion: EVH is a safe and viable technique for obtaining saphenous vein conduit for CABG Additional studies are warranted to improve understanding of mechanism by which EVH influences long-term outcomes, as well as how clinical teams can maximize the utility of this technique 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2): 147-53

EVH - Schlussfolgerung Sicheres und praktikables Verfahren Datenlage zeigt durchweg geringere Wundkomplikationsraten Sehr gutes kosmetisches Ergebnis erhöhte Patientenzufriedenheit Prospektiv-randomisierte Studien Langzeitergebnisse nach EVH (EVH vs. MIVH) Kostenanalyse